NEW YORK: Pfizer reported higher quarterly profits Tuesday as it lifted its full-year forecast for coronavirus vaccine sales and predicted Covid-19 would yield billions more in revenues for the forseeable future.The big US drugmaker now expects 2022 sales of the Comirnaty Covid-19 vaccine of $34 billion, up $2 billion from the prior outlook.Pfizer maintained its projection of $22 billion in annual sales for its Paxlovid therapeutic for Covid-19.More than two years into the pandemic, Chief Executive Albert Bourla predicted revenues for Covid-19 products would persist even though they are likely to fall from their 2022 levels.“We believe our Covid-19 franchises will remain multi-billion revenu
Hence then, the article about pfizer lifts 2022 forecast for covid 19 vaccine sales as profits rise was published today ( ) and is available onDaily Sun ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Pfizer lifts 2022 forecast for Covid-19 vaccine sales as profits rise )